Change Healthcare Inc. CHNG
Set alert
27.49 0.00 0.00%
At close · Sep 30
27.43 Day range 27.55
52-week range unavailable
- Open
- 27.47
- Prev close
- 27.49
- Mkt cap
- 0
- Vol
- 28.98M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 27.43
- High
- 27.55
- Forward P/E
- 16.97
- Beta
- 1.02
- Short ratio
- 6.71
- Inst. own
- 94.74%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2022
- 50-d avg
- 25.26
- 200-d avg
- 22.97
- 1y target
- 26.42
Analyst view
Consensus: buy
Buy
Price target (mean) 26.42 -3.9% downside
Now 27.49
- Target (low)
- 25.75
- Target (mean)
- 26.42
- Target (high)
- 27.75
Ratings (-1m) 10 4 buy · 6 hold · 0 sell
- Strong buy2
- Buy2
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 10
- 2 months ago 10
- 3 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22 | 0.20 – 0.25 | 0.35 | -37.1% | 839.65M | +1.6% | 2 |
| Next quarter | 0.35 | 0.32 – 0.38 | 0.36 | -2.8% | 890.25M | 0.0% | 2 |
| Current year | 1.46 | 1.35 – 1.58 | 1.53 | -4.6% | 3.59B | +3.0% | 3 |
| Next year | 1.62 | 1.55 – 1.68 | 1.46 | +11.0% | 3.74B | +4.3% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 20, 2022 | Citigroup | Downgrade | Buy | Neutral |
| Sep 20, 2022 | Piper Sandler | Downgrade | Overweight | Neutral |
| Sep 7, 2022 | Truist Securities | Initiated | — | Hold |
| Jun 1, 2022 | Citigroup | Maintained | — | Buy |
| May 31, 2022 | Credit Suisse | Maintained | — | Neutral |
| Jan 11, 2021 | Berenberg | Downgrade | Buy | Hold |
| Jan 8, 2021 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| Jan 8, 2021 | Deutsche bank | Downgrade | Buy | Hold |
| Jan 7, 2021 | RBC Capital | Downgrade | Outperform | Sector Perform |
| Jan 7, 2021 | Credit Suisse | Downgrade | Outperform | Neutral |
| Jan 7, 2021 | Guggenheim | Downgrade | Buy | Neutral |
| Dec 15, 2020 | SVB Leerink | Maintained | — | Outperform |
| Dec 8, 2020 | Berenberg | Initiated | — | Buy |
| Nov 9, 2020 | Credit Suisse | Maintained | — | Outperform |
| Nov 5, 2020 | Cantor Fitzgerald | Maintained | — | Overweight |
| Sep 28, 2020 | Credit Suisse | Maintained | — | Outperform |
| Aug 7, 2020 | SVB Leerink | Maintained | — | Outperform |
| Jul 14, 2020 | Citigroup | Initiated | — | Buy |
| Jun 8, 2020 | Deutsche Bank | Maintained | — | Buy |
| Jun 5, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Apr 22, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Apr 17, 2020 | Deutsche Bank | Maintained | — | Buy |
| Apr 13, 2020 | B of A Securities | Maintained | — | Buy |
| Apr 13, 2020 | Credit Suisse | Maintained | — | Outperform |
| Apr 9, 2020 | Barclays | Maintained | — | Overweight |
| Mar 26, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| Mar 18, 2020 | Credit Suisse | Maintained | — | Outperform |
| Mar 18, 2020 | Raymond James | Upgrade | Outperform | Strong Buy |
| Mar 10, 2020 | Wells Fargo | Upgrade | Equal-Weight | Overweight |
| Feb 14, 2020 | Deutsche Bank | Maintained | — | Buy |